153 related articles for article (PubMed ID: 16153636)
21. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems.
Tachibana K; Matsumoto M; Koseki H; Togashi H; Kojima T; Morimoto Y; Yoshioka M
J Psychopharmacol; 2006 Jul; 20(4):562-9. PubMed ID: 16401668
[TBL] [Abstract][Full Text] [Related]
23. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex.
Yoshitake T; Yoshitake S; Fujino K; Nohta H; Yamaguchi M; Kehr J
J Neurosci Methods; 2004 Dec; 140(1-2):163-8. PubMed ID: 15589346
[TBL] [Abstract][Full Text] [Related]
24. Anesthetics decreased the microdialysis extraction fraction of norepinephrine but not dopamine in the medial prefrontal cortex.
Pan WH; Lai YJ
Synapse; 1995 Sep; 21(1):85-92. PubMed ID: 8525466
[TBL] [Abstract][Full Text] [Related]
25. Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex.
Zocchi A; Fabbri D; Heidbreder CA
Neurosci Lett; 2005 Oct; 387(3):157-61. PubMed ID: 16023290
[TBL] [Abstract][Full Text] [Related]
26. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.
Invernizzi RW; Parini S; Sacchetti G; Fracasso C; Caccia S; Annoni K; Samanin R
Br J Pharmacol; 2001 Jan; 132(1):183-8. PubMed ID: 11156576
[TBL] [Abstract][Full Text] [Related]
27. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex.
Mizoguchi K; Tanaka Y; Tabira T
J Ethnopharmacol; 2010 Jan; 127(1):70-6. PubMed ID: 19799980
[TBL] [Abstract][Full Text] [Related]
29. Oseltamivir (Tamiflu) increases dopamine levels in the rat medial prefrontal cortex.
Yoshino T; Nisijima K; Shioda K; Yui K; Kato S
Neurosci Lett; 2008 Jun; 438(1):67-9. PubMed ID: 18457919
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats.
Bel N; Artigas F
Neuropsychopharmacology; 1999 Dec; 21(6):745-54. PubMed ID: 10633480
[TBL] [Abstract][Full Text] [Related]
31. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.
Murata M; Katagiri N; Ishida K; Abe K; Ishikawa M; Utsunomiya I; Hoshi K; Miyamoto K; Taguchi K
Brain Res; 2009 May; 1269():40-6. PubMed ID: 19285043
[TBL] [Abstract][Full Text] [Related]
32. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
[TBL] [Abstract][Full Text] [Related]
33. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
[TBL] [Abstract][Full Text] [Related]
34. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
Hernández LF; Segovia G; Mora F
Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
[TBL] [Abstract][Full Text] [Related]
35. Chronopharmacological Analysis of Antidepressant Activity of a Dual-Action Serotonin Noradrenaline Reuptake Inhibitor (SNRI), Milnacipran, in Rats.
Kawai H; Machida M; Ishibashi T; Kudo N; Kawashima Y; Mitsumoto A
Biol Pharm Bull; 2018; 41(2):213-219. PubMed ID: 29386481
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
Amargós-Bosch M; Adell A; Artigas F
J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545
[TBL] [Abstract][Full Text] [Related]
37. 6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex.
Devoto P; Flore G; Saba P; Castelli MP; Piras AP; Luesu W; Viaggi MC; Ennas MG; Gessa GL
J Neurosci Res; 2008 May; 86(7):1647-58. PubMed ID: 18189323
[TBL] [Abstract][Full Text] [Related]
38. Preclinical pharmacology of milnacipran.
Briley M; Prost JF; Moret C
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():9-14. PubMed ID: 8923122
[TBL] [Abstract][Full Text] [Related]
39. Milnacipran remediates impulsive deficits in rats with lesions of the ventromedial prefrontal cortex.
Tsutsui-Kimura I; Yoshida T; Ohmura Y; Izumi T; Yoshioka M
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522418
[TBL] [Abstract][Full Text] [Related]
40. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Liang YQ; Tang XC
Acta Pharmacol Sin; 2006 Sep; 27(9):1127-36. PubMed ID: 16923332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
